The Triple Agonist Advantage: Silencing Food Noise Retatrutide is unique because it targets three different hormone receptors: GLP-1, GIP, and glucagon
With the considerable heterogeneity and complexity across the class of GLP-1 RAs, each agent should be evaluated independently, as opposed to assuming a class effect, and head-to-head clinical trials can lend important information regarding differences within the GLP-1 RA class
How compounded tirzepatide expiration compares to other GLP-1 medications If you use or have considered other GLP-1 receptor agonists alongside or instead of tirzepatide, understanding how expiration timelines compare helps you make informed decisions about your protocol
Sibai BM, Caritis S, Hauth J, et al
Severe hypoglycemia is an unpredictable event for people with diabetes that can happen anytime, anywhere, Sherry Martin, MD, vice president of Lilly Medical Affairs, said in a company press release